Healthcare consulting and technology company D2 Solutions announced on Thursday that it has acquired ProModRx, a cloud-based technology platform designed to help speed patient access to prescription medications.
This acquisition aims to expand D2's services to better assist pharmaceutical and medical device manufacturers, traditional hubs and pharmacies across the full scope of the patient journey. That support includes therapy initiation, prescription capture, electronic benefits verification, prior authorisation support, dispensing coordination and ongoing patient engagement.
The deal is also expected to strengthen D2's support for pharmaceutical and medical device manufacturers that depend on reimbursement support, enrolment and product access coordination and extends its offering across retail, hospital, mail-order and specialty pharmacy channels.
As part of the acquisition, ProModRx employees will continue to support the business and Jerry Smith, ProModRx's general manager, will be joining D2 Solutions' executive team.
Merz Therapeutics and Kvvit sign exclusive agreement for INBRIJA in Greater China
Implantica submits final FDA response for RefluxStop PMA application
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
AngioDynamics reports 24-month PRESERVE data showing durable NanoKnife outcomes in prostate cancer
Cepheid receives CE mark for IVDR‑compliant gastrointestinal PCR panel
Abingdon Health supports UK launch of LVOne stroke triage test
Fesarius Therapeutics reports publication of DermiSphere hDRT data
Shield Therapeutics announces Phase II trial initiation of ACCRUFeR in Japan for PAH
Johnson & Johnson secures EU approval for ETHICON 4000 surgical stapler